Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 91 articles:
HTML format



Single Articles


    July 2026
  1. TANG NSY, Teng MLP, Selvakumar A, Ng CWH, et al
    Delisting From Clinical Improvement in Liver Cirrhosis: A Machine Learning Decision Tree Analysis.
    Transplantation. 2026;110:e1447-e1455.
    PubMed     Abstract available


  2. AMARA D, Melehy A, Feng J, Rodgers A, et al
    Automated Computed Tomography-based Liver Steatosis Risk Stratification of Deceased Organ Donors Using Real-world Data.
    Transplantation. 2026;110:e1475-e1484.
    PubMed     Abstract available


  3. MAROTO-SERRAT C, Marin-Blazquez M, Sanus F, Caballeria-Casals A, et al
    Visceral Adipose Tissue and its Crosstalk With the Liver Allograft: Implications for Transplant Outcomes.
    Transplantation. 2026;110:e1391-e1401.
    PubMed     Abstract available


    June 2026
  4. YAMABE S, Kuse Y, Okumura T, Kasai T, et al
    Oxygenated Perfusion Enhances Hepatocyte Function in Human iPSC-liver Tissue.
    Transplantation. 2026 Jun 10. doi: 10.1097/TP.0000000000005684.
    PubMed     Abstract available


  5. KORATALA A, Kazory A
    Hepato-Cardio-Renal Interactions and Transplant Implications.
    Transplantation. 2026 Jun 9. doi: 10.1097/TP.0000000000005794.
    PubMed     Abstract available


    May 2026
  6. THIERRY G, Piette B, Navez M, Koch JN, et al
    Oncologic Safety of Irradiated-only Autologous Blood Transfusion in Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Cohort Study.
    Transplantation. 2026 May 28. doi: 10.1097/TP.0000000000005760.
    PubMed     Abstract available


  7. KOH YX, Zhao Y, Chua DW, Ooi LLPJ, et al
    Global Disparities in Liver Transplantation Relative to the Burden of Cirrhosis and Other Chronic Liver Diseases (2000-2023).
    Transplantation. 2026 May 18. doi: 10.1097/TP.0000000000005750.
    PubMed     Abstract available


  8. HSU SC, Yang HR, Chen SH, Chen TH, et al
    Systemic Treatment Strategies for Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A 20-y Retrospective Analysis With Clinical Insights.
    Transplantation. 2026 May 1. doi: 10.1097/TP.0000000000005702.
    PubMed     Abstract available


    April 2026
  9. CHOI HH, Choi Y, Kim JY, Kim J, et al
    Hepatic Congestion-linked Intrahepatic Biliary Strictures After Living Donor Liver Transplantation.
    Transplantation. 2026 Apr 27. doi: 10.1097/TP.0000000000005730.
    PubMed     Abstract available


  10. MALUF DG, Al-Adra D, Mas VR
    Reprogramming Hepatic Resilience: BMK1 as a Cytoprotective Axis in Liver Ischemia-reperfusion Injury.
    Transplantation. 2026 Apr 21. doi: 10.1097/TP.0000000000005743.
    PubMed    


  11. NAKAYAMA T, Esquivel CO, Melcher ML, Sasaki K, et al
    Survival Benefit of Accepting Livers From Donation After Circulatory Death Donors Older Than or Equal to 60 y in the United States.
    Transplantation. 2026;110:e856-e865.
    PubMed     Abstract available


    March 2026
  12. KROEMER A, Moris D, Nijhar K, Jia II, et al
    Expanding Pediatric Liver Transplant Options: On-pump Split Reduction With Normothermic Machine Perfusion.
    Transplantation. 2026 Mar 30. doi: 10.1097/TP.0000000000005653.
    PubMed     Abstract available


  13. DONNELLY C, Kim JI, Motter JD, Ishaque T, et al
    Temporal Changes in Access to Transplantation Among Pediatric Registrants.
    Transplantation. 2026;110:e637-e646.
    PubMed     Abstract available


    February 2026
  14. KIM SM, Oh RK, Yoon YI, Choi WM, et al
    Renal Recovery Benefit of Living Versus Deceased Donor Liver Transplantation in Recipients With High Model for End-Stage Liver Disease Scores: A Propensity Score-matched Study.
    Transplantation. 2026 Feb 16. doi: 10.1097/TP.0000000000005656.
    PubMed     Abstract available


  15. MUFTI A, Farr M
    Cirrhotic Cardiomyopathy: Moving From Description to Intervention.
    Transplantation. 2026 Feb 3. doi: 10.1097/TP.0000000000005655.
    PubMed    


  16. TANAKA T, Jones MP, Wehby G, Axelrod D, et al
    Impact of Model for End-stage Liver Disease Cutoffs on Liver Transplant Access in the United States: A Regression Discontinuity Design.
    Transplantation. 2026 Feb 2. doi: 10.1097/TP.0000000000005650.
    PubMed     Abstract available


    January 2026
  17. FALEIRO MD, de M Ogawa T, Correia PP, Perim V, et al
    Updated Systematic Review and Meta-Analysis of Duct-to-duct Versus Hepaticojejunostomy Reconstruction After Liver Transplantation for Primary Sclerosing Cholangitis.
    Transplantation. 2026 Jan 23. doi: 10.1097/TP.0000000000005639.
    PubMed     Abstract available


  18. HILL A, Hu Y, Park Y, Lovasik B, et al
    Low Model for End-Stage Liver Disease Score Patients Experience Significant Survival Advantage With Liver Transplantation.
    Transplantation. 2026 Jan 5. doi: 10.1097/TP.0000000000005601.
    PubMed     Abstract available


    December 2025
  19. MENG Q, Chen H, Li J, Qin M, et al
    Ischemia-free Liver Transplantation: 7-y Experience From a Single-center Cohort in China.
    Transplantation. 2025 Dec 2. doi: 10.1097/TP.0000000000005555.
    PubMed     Abstract available


    November 2025
  20. CLARKE G, Mao J, Hann A, Fan Y, et al
    Evaluation of Liver Maximum Capacity Measurements to Monitor Hepatocellular Function During Extended Normothermic Machine Perfusion.
    Transplantation. 2025 Nov 17. doi: 10.1097/TP.0000000000005570.
    PubMed     Abstract available


  21. GILL M, Abhayaratna C, Brieger D, Huang J, et al
    Cirrhotic Cardiomyopathy Predicts New-onset Heart Failure Within the First Year After Liver Transplantation.
    Transplantation. 2025 Nov 17. doi: 10.1097/TP.0000000000005539.
    PubMed     Abstract available


  22. WALLER D, Chinnakotla S, Ramanathan K, Brierton J, et al
    Liver Retransplantation: Identifying Factors and Developing a Risk Prediction Model to Predict Futility in the Modern Era.
    Transplantation. 2025;109:1765-1773.
    PubMed     Abstract available


    October 2025
  23. MARTINEZ-ARENAS L, Carvalho-Gomes A, Vidal E, Brandman D, et al
    The Relentless Progression of Metabolic Dysfunction-associated Steatotic Liver Disease in Liver Transplantation in Spain.
    Transplantation. 2025 Oct 31. doi: 10.1097/TP.0000000000005554.
    PubMed     Abstract available


  24. HASJIM BJ, Paukner M, Kwong AJ, Bhat M, et al
    Impact of the 6-mo Wait Policy on Transplantation, Resection, and Ablation Outcomes for Patients With Hepatocellular Carcinoma: A National Cancer Database Analysis.
    Transplantation. 2025 Oct 13. doi: 10.1097/TP.0000000000005536.
    PubMed     Abstract available


  25. GUO H, Gala-Lopez BL, Alwayn IPJ, Hewitt KC, et al
    Liver Discard Rate Attributable to Conservative Estimations of Steatosis: An Inference-based Approach.
    Transplantation. 2025;109:e609-e618.
    PubMed     Abstract available


    September 2025
  26. NGONADI C, Hopkins LJ, Williams FR, Armstrong MJ, et al
    Physical Frailty and Sarcopenia in Liver Transplantation: How Should They Be Assessed and Addressed?
    Transplantation. 2025 Sep 22. doi: 10.1097/TP.0000000000005519.
    PubMed     Abstract available


  27. MASPERO M, Sposito C, Wehrle C, Bongini M, et al
    Post-recurrence Survival After Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2025 Sep 8. doi: 10.1097/TP.0000000000005514.
    PubMed     Abstract available


    August 2025
  28. YANG M, Wang J, Li C, Yang Z, et al
    Serine Glycine Restriction Aggravates Hepatic Ischemia-reperfusion Injury.
    Transplantation. 2025 Aug 22. doi: 10.1097/TP.0000000000005487.
    PubMed     Abstract available


  29. WU S, Li G, Zhou B, Zhang S, et al
    Auxiliary Liver Transplantation With Delayed Total Hepatectomy: Evolution From 2-stage APOLT to RAPID Following the ALPPS Principles.
    Transplantation. 2025 Aug 13. doi: 10.1097/TP.0000000000005501.
    PubMed     Abstract available


    July 2025
  30. SEMENOVA M, Liukkonen V, Markkinen S, Farkkila M, et al
    The Impact of Genome-wide Histocompatibility on Liver Transplantation Outcomes.
    Transplantation. 2025 Jul 14. doi: 10.1097/TP.0000000000005475.
    PubMed     Abstract available


  31. MALIK AK, Mann DA
    Comment on "G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression".
    Transplantation. 2025 Jul 11. doi: 10.1097/TP.0000000000005499.
    PubMed    


    June 2025
  32. LIU JY, Liao W, Chen ZY, Liu T, et al
    PKM2 Drives Lactate-mediated Fibrosis in Liver Transplantation.
    Transplantation. 2025 Jun 27. doi: 10.1097/TP.0000000000005461.
    PubMed     Abstract available


  33. BYRNE MM, Chavez-Villa M, Endo Y, Jimenez-Soto C, et al
    Live Donor Liver Transplantation for Oncologic Indications.
    Transplantation. 2025 Jun 11. doi: 10.1097/TP.0000000000005427.
    PubMed     Abstract available


    May 2025
  34. XIE C, Qiu N, Wang C, Chen J, et al
    G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression.
    Transplantation. 2025 May 8. doi: 10.1097/TP.0000000000005412.
    PubMed     Abstract available


  35. MONTI C, Hong SK, Lee A, Hong JC, et al
    Acute Response of Hepatocyte MRP2 Internalization as an Indicator of Ischemia-Reperfusion Injury in Liver Transplantation.
    Transplantation. 2025 May 5. doi: 10.1097/TP.0000000000005418.
    PubMed     Abstract available


  36. KARLINSKI VIZENTIN V, Antunes V, Ferreira Felix I, Florencio de Mesquita C, et al
    Combined Heart and Liver Transplantation in the Failing Fontan: Systematic Review and Single-arm Meta-analysis.
    Transplantation. 2025 May 5. doi: 10.1097/TP.0000000000005400.
    PubMed     Abstract available


  37. MALIK TH, Keeney E, Jang A, Hafeez MS, et al
    Is the Transplantation of Elderly and DCD Donors in Low MELD Recipients Justified: An Intent-to-treat Analysis.
    Transplantation. 2025;109:823-831.
    PubMed     Abstract available


    April 2025
  38. MAGYAR CTJ, Jones O, Rajendran L, Carrique L, et al
    Living Donor Liver Transplantation for Alcohol-related Liver Disease: An Intention-to-treat Analysis.
    Transplantation. 2025 Apr 24. doi: 10.1097/TP.0000000000005410.
    PubMed     Abstract available


  39. HONG G, Han DK, Rhu J, Hong SK, et al
    Safety and Therapeutic Outcomes of Adjuvant Immunotherapy With Autologous Cytokine-induced Killer Cells for Patients With Hepatocellular Carcinoma Beyond Milan Criteria After Liver Transplantation.
    Transplantation. 2025 Apr 16. doi: 10.1097/TP.0000000000005406.
    PubMed     Abstract available


  40. THULUVATH AJ, Polineni P, Morrissey S, Belfanti K, et al
    Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study.
    Transplantation. 2025;109:e202-e212.
    PubMed     Abstract available


    March 2025
  41. WEHRLE CJ, Kusakabe J, Nakayama T, Miller C, et al
    Time to Expand Selection Criteria for MELD Exception Points in Liver Transplantation for Hepatocellular Carcinoma.
    Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005396.
    PubMed    


  42. YAKUBU I, Spengler J, Taylor P, LaPorte M, et al
    Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients.
    Transplantation. 2025 Mar 25. doi: 10.1097/TP.0000000000005361.
    PubMed     Abstract available


    February 2025
  43. LACOM C, Kothari RP, Mendez NV, Galli A, et al
    Safety and Feasibility of Early Extubation in Liver Transplantation: Experience in 1555 Patients.
    Transplantation. 2025 Feb 14. doi: 10.1097/TP.0000000000005356.
    PubMed     Abstract available


    January 2025
  44. LI Z, Raptis D, Rammohan A, Gunasekaran V, et al
    Validation of a Pretransplant Risk Prediction Model for Early Allograft Dysfunction After Living-donor Liver Transplantation.
    Transplantation. 2025 Jan 28. doi: 10.1097/TP.0000000000005331.
    PubMed     Abstract available


  45. GU Y, Li Y, Zhang C, Liu Y, et al
    BCL6 Alleviates Hepatic Ischemia/Reperfusion Injury Via Recruiting SIRT1 to Repress the NF-kappaB/NLRP3 Pathway.
    Transplantation. 2025 Jan 13. doi: 10.1097/TP.0000000000005305.
    PubMed     Abstract available


  46. SAKOWITZ S, Bakhtiyar SS, Mallick S, Kaldas F, et al
    Association of Community Socioeconomic Distress With Waitlist and Survival Outcomes in Liver Transplantation.
    Transplantation. 2025 Jan 9. doi: 10.1097/TP.0000000000005328.
    PubMed     Abstract available


  47. MANKOWSKI MA, Wood NL, Massie AB, Segev DL, et al
    Targeted Broader Sharing for Liver Continuous Distribution.
    Transplantation. 2025;109:e36-e44.
    PubMed     Abstract available


    December 2024
  48. JATANA S, Krys D, Verhoeff K, Kung JY, et al
    Liver Allograft Cirrhosis, Retransplant, and Mortality Secondary to Recurrent Disease After Transplant for MASH: A Systematic Review and Meta-analysis.
    Transplantation. 2024 Dec 11. doi: 10.1097/TP.0000000000005276.
    PubMed     Abstract available


    November 2024
  49. MAGYAR CTJ, Perera S, Rajendran L, Li Z, et al
    Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
    Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005240.
    PubMed     Abstract available


    October 2024
  50. NAM HJ, Kim DG, Min EK, Lee JG, et al
    Preoperative Factors Affecting Graft Survival After ABO-incompatible Adult Liver Transplantation.
    Transplantation. 2024 Oct 23. doi: 10.1097/TP.0000000000005231.
    PubMed     Abstract available


  51. SATAPATHY SK, Elwir S, Brandman D, Smith C, et al
    Risk Stratification for Chronic Kidney Disease After Liver Transplant for Metabolic Dysfunction-associated Steatohepatitis (MASH) Cirrhosis: Results From the NailMASH Consortium.
    Transplantation. 2024 Oct 22. doi: 10.1097/TP.0000000000005236.
    PubMed     Abstract available


  52. MATSUMOTO R, Verna EC, Rosenblatt R, Emond JC, et al
    No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD Era.
    Transplantation. 2024;108:2100-2108.
    PubMed     Abstract available


    September 2024
  53. BERARDI G, Guglielmo N, Cucchetti A, Usai S, et al
    Transarterial Radioembolization Can Downstage Intermediate and Advanced Hepatocellular Carcinoma to Liver Transplantation.
    Transplantation. 2024 Sep 17. doi: 10.1097/TP.0000000000005204.
    PubMed     Abstract available


  54. JO HS, Kim DS, Cho JY, Hwang S, et al
    Comparison of Clinical Outcomes Using Left and Right Liver Grafts in Adult-to-adult Living-donor Liver Transplantation: A Retrospective Cohort Study Using the Korean Organ Transplantation Registry.
    Transplantation. 2024 Sep 9. doi: 10.1097/TP.0000000000005200.
    PubMed     Abstract available


    July 2024
  55. KRISHNAN SK, Ramakrishna SH, Malleeswaran S, Kasala MB, et al
    Auxiliary Partial Orthotopic Liver Transplantation Is a Safe and Effective Option for Yellow Phosphorus Toxin-induced Acute Liver Failure.
    Transplantation. 2024 Jul 24. doi: 10.1097/TP.0000000000005163.
    PubMed     Abstract available


  56. TANAKA T, Ross-Driscoll K, Pancholia S, Axelrod D, et al
    Body Size Remains the Major Source of Sex Disparity Despite Updated Liver Transplant Allocation Policies.
    Transplantation. 2024 Jul 18. doi: 10.1097/TP.0000000000005142.
    PubMed     Abstract available


    June 2024
  57. WEHRLE CJ, Kusakabe J, Akabane M, Maspero M, et al
    Expanding Selection Criteria in Deceased Donor Liver Transplantation for Hepatocellular Carcinoma: Long-term Follow-up of a National Registry and 2 Transplant Centers.
    Transplantation. 2024 Jun 4. doi: 10.1097/TP.0000000000005097.
    PubMed     Abstract available


    May 2024
  58. FRANCOZ C, Joly D, Legendre C
    Liver Transplantation for Polycystic Liver Disease: Definitely not a Cosmetic Surgery.
    Transplantation. 2024 May 21. doi: 10.1097/TP.0000000000005066.
    PubMed    


  59. CILLO U, Lauterio A, Furlanetto A, Canitano N, et al
    Full-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion.
    Transplantation. 2024 May 17. doi: 10.1097/TP.0000000000005039.
    PubMed     Abstract available


  60. ZHAN M, Liu D, Yao L, Wang W, et al
    Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway.
    Transplantation. 2024 May 10. doi: 10.1097/TP.0000000000005036.
    PubMed     Abstract available


    April 2024
  61. CONCORS SJ, Hernandez PT, O'Brien C, DePaolo J, et al
    Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
    Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005042.
    PubMed     Abstract available


  62. RAJAKANNU M, Rammohan A, Narasimhan G, Murugesan S, et al
    Deceased Donor Liver Transplantation in India: First Report of 5-Y Outcomes.
    Transplantation. 2024 Apr 19. doi: 10.1097/TP.0000000000004991.
    PubMed     Abstract available


  63. EMAMAULLEE J, Bartlett JMA, Bangerth S, Etesami K, et al
    Response Regarding Application of the CHALF Score in Pediatric Acute Liver Failure.
    Transplantation. 2024;108:e66-e67.
    PubMed    


  64. YADAV D, Lal BB, Sood V, Khanna R, et al
    Prognostication in Pediatric Acute Liver Failure Using CHALF Score-"Perspective From the Opposite Shore".
    Transplantation. 2024;108:e64-e65.
    PubMed    


    March 2024
  65. MIYAKE K, Kim DY, Chau LC, Trudeau S, et al
    Exception Policy Change Increased the Simultaneous Kidney-liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004950.
    PubMed     Abstract available


  66. ISHAQUE T, Beckett J, Gentry S, Garonzik-Wang J, et al
    Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004957.
    PubMed     Abstract available


    February 2024
  67. BECKER EC, Siddique O, O'Sullivan DM, Dar W, et al
    Disparities in Liver Transplantation for Nonalcoholic Steatohepatitis in Women.
    Transplantation. 2024 Feb 29. doi: 10.1097/TP.0000000000004964.
    PubMed     Abstract available


  68. TOSHIMA T, Harada N, Itoh S, Tomiyama T, et al
    What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation?
    Transplantation. 2024 Feb 27. doi: 10.1097/TP.0000000000004952.
    PubMed     Abstract available


  69. MIYAKE K, Chau LC, Trudeau S, Kitajima T, et al
    Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.
    Transplantation. 2024 Feb 27. doi: 10.1097/TP.0000000000004955.
    PubMed     Abstract available


  70. ELSOKARY K, Samuel S, Koizumi N, Ortiz J, et al
    Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Transplantation. 2024;108:e21.
    PubMed    


  71. CROSS-NAJAFI AA, Farag K, Chen AM, Smith LJ, et al
    The Long Road to Develop Custom-built Livers: Current Status of 3D Liver Bioprinting.
    Transplantation. 2024;108:357-368.
    PubMed     Abstract available


    January 2024
  72. JAN MY, Patidar KR, Ghabril MS, Kubal CA, et al
    Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities.
    Transplantation. 2024 Jan 9. doi: 10.1097/TP.0000000000004851.
    PubMed     Abstract available


    December 2023
  73. SCHMIDT K, Spann A, Khan MQ, Izzy M, et al
    Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation.
    Transplantation. 2023 Dec 7. doi: 10.1097/TP.0000000000004875.
    PubMed     Abstract available


  74. ZHOU K, Lit A, Kuo LS, Thompson LK, et al
    Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.
    Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004888.
    PubMed     Abstract available


    November 2023
  75. KUSAKABE J, Kozato A, Tajima T, Bekki Y, et al
    Reappraisal of Donor Age in Liver Transplantation: NASH as a Potential Target to Safely Utilize Old Liver Grafts.
    Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004865.
    PubMed     Abstract available


  76. RASTOGI A, Gupta AA, Piplani T, Yadav KS, et al
    Hilar Anatomy in 3035 Living Liver Donors: A Novel Classification for Donor Surgery and Suitability, Hepatic Surgeries, and Hepatobiliary Interventions.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004807.
    PubMed     Abstract available


  77. MAHMUD N, Yagan L, Hoteit MA, Reddy KR, et al
    Significant Reduction in Posttransplant Hepatocellular Carcinoma Recurrence in the Post 6-Mo Waiting Policy Era.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004860.
    PubMed     Abstract available


  78. SNEIDERS D, van Dijk ARM, Darwish-Murad S, van Rosmalen M, et al
    Quantifying the Disadvantage of Small Recipient Size on the Liver Transplantation Waitlist, a Longitudinal Analysis Within the Eurotransplant Region.
    Transplantation. 2023 Nov 13. doi: 10.1097/TP.0000000000004804.
    PubMed     Abstract available


  79. WANG JH, Pfeiffer RM, Musgrove D, Castenson D, et al
    Cancer Mortality Among Solid Organ Transplant Recipients in the United States During 1987-2018.
    Transplantation. 2023;107:2433-2442.
    PubMed     Abstract available


    October 2023
  80. SEDKI M, Kwong A, Bhargava M, Ahmed A, et al
    Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
    Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004800.
    PubMed     Abstract available


  81. ASCHER-BARTLETT JM, Bangerth S, Jordan S, Weaver C, et al
    CHALF Score: A Novel Tool to Rapidly Risk Stratify Children in Need of Liver Transplant Evaluation During Acute Liver Failure.
    Transplantation. 2023 Oct 23. doi: 10.1097/TP.0000000000004845.
    PubMed     Abstract available


  82. DEEP A
    Organ Allocation in Children With Chronic Liver Disease: Quest for an Ideal Prognostic Model Continues!
    Transplantation. 2023;107:e242-e244.
    PubMed    


  83. AHN DJ, Zeng S, Pelzer KM, Barth RN, et al
    The Accuracy of Nonstandardized MELD/PELD Score Exceptions in the Pediatric Liver Allocation System.
    Transplantation. 2023;107:e247-e256.
    PubMed     Abstract available


  84. ZENDEL A, Renzo CD, Rocha C, Samuel B, et al
    P5.3: Successful liver transplantation using a deceased donor liver with glycogenic hepatopathy pathologic appearance.
    Transplantation. 2023;107.
    PubMed    


  85. RODRIGUEZ-DAVALOS MI, Lopez-Verdugo F, Kasahara M, Muiesan P, et al
    International Liver Transplantation Society Global Census: First Look at Pediatric Liver Transplantation Activity Around the World.
    Transplantation. 2023;107:2087-2097.
    PubMed     Abstract available


    September 2023
  86. AZOULAY D, Desterke C, Bhangui P, Serrablo A, et al
    Rescue Liver Transplantation for Posthepatectomy Liver Failure: A Systematic Review and Survey of an International Experience.
    Transplantation. 2023 Sep 26. doi: 10.1097/TP.0000000000004813.
    PubMed     Abstract available


    August 2023
  87. ROSENTHAL BE, Abt PL, Schaubel DE, Reddy KR, et al
    Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience.
    Transplantation. 2023 Aug 28. doi: 10.1097/TP.0000000000004767.
    PubMed     Abstract available


    July 2023
  88. THULUVATH AJ, Duarte-Rojo A, Lai JC, Peipert J, et al
    Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant Candidates.
    Transplantation. 2023 Jul 27. doi: 10.1097/TP.0000000000004741.
    PubMed     Abstract available


  89. HASSOUNEH R, Flynn S, Shen S, Tseng M, et al
    Impact of Liver Transplantation on Adipose Tissue Compartments and Its Association With Metabolic Sequela.
    Transplantation. 2023 Jul 12. doi: 10.1097/TP.0000000000004704.
    PubMed     Abstract available


  90. BRANAGAN WT, Norvell JP
    Assessment and Evaluation of Alcohol Use Disorder in Liver Transplant.
    Transplantation. 2023 Jul 6. doi: 10.1097/TP.0000000000004722.
    PubMed     Abstract available


    June 2023
  91. COTTER TG, Mitchell MC, Patel MJ, Anouti A, et al
    Racial and Ethnic Disparities in Liver Transplantation for Alcohol-associated Liver Diseases in the United States.
    Transplantation. 2023 Jun 21. doi: 10.1097/TP.0000000000004701.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum